A new instrument at Columbia University will help scientists uncover the full potential of heavy ion radiation therapy. The linac (linear accelerator) booster, supported by grants from New York’s Empire State Development and the National Cancer Institute, establishes Columbia as the first institution in the United States with an instrument dedicated to research on heavy ion radiation therapy. Read more . . . .
Heavy ions could radically improve radiation therapy for treatment of pancreatic cancer and other difficult-to-treat tumors if researchers can better understand how the ions work against cancer.